EV/EBITDA:
-7.99-0.10(-1.27%)Summary
- As of today, CRSP EV/EBITDA is -7.99, with a fall of -0.10 (-1.27%) during the current trading session.
- Over the past year, CRSP EV/EBITDA has dropped by -1.28 (-19.08%).
- CRSP EV/EBITDA is now -100.37% below its all-time high of 2142.90.
Performance
CRSP EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
CRSP EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise ValueEnterprise Value | PricePrice |
|---|---|---|---|
| 1D1 Day | -1.3% | +1.3% | +0.9% |
| 1M1 Month | -3.1% | +3.0% | +2.0% |
| 3M3 Months | +9.6% | -5.0% | -4.4% |
| 6M6 Months | -74.1% | +75.6% | +30.7% |
| YTDYTD | -110.8% | +116.7% | +43.4% |
| 1Y1 Year | -19.1% | +74.7% | +26.5% |
| 5Y5 Years | +80.5% | -60.5% | -62.1% |
CRSP EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs Highvs High | LowLow | Current vs Lowvs Low | |
|---|---|---|---|---|---|
| 1M | 1-Month | -6.50 | -22.9% | -8.35 | +4.3% |
| 3M | 3-Month | -6.50 | -22.9% | -11.96 | +33.2% |
| 6M | 6-Month | -4.59 | -74.1% | -11.96 | +33.2% |
| 1Y | 1-Year | -2.33 | -242.9% | -11.96 | +33.2% |
| 3Y | 3-Year | -2.13 | -275.1% | -33.74 | +76.3% |
| 5Y | 5-Year | 21.60 | -137.0% | -48.40 | +83.5% |
| All-Time | All-Time | 2142.90 | -100.4% | -759.60 | +99.0% |
CRSP EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.99(-110.8%) |
| 2024 | -3.79(+80.9%) |
| 2023 | -19.83(-693.2%) |
| 2022 | -2.50(-126.6%) |
| 2021 | 9.40(+133.5%) |
| Date | Value |
|---|---|
| 2020 | -28.06(-151.6%) |
| 2019 | 54.42(+925.8%) |
| 2018 | -6.59(+43.1%) |
| 2017 | -11.59(-59.0%) |
| 2016 | -7.29 |
FAQ
- What is CRISPR Therapeutics AG EV/EBITDA?
- What is the all-time high EV/EBITDA for CRISPR Therapeutics AG?
- What is CRSP EV/EBITDA year-to-date change?
- What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
What is CRISPR Therapeutics AG EV/EBITDA?
The current EV/EBITDA of CRSP is -7.99
What is the all-time high EV/EBITDA for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high EV/EBITDA is 2142.90
What is CRSP EV/EBITDA year-to-date change?
CRISPR Therapeutics AG EV/EBITDA has changed by -4.20 (-110.82%) since the beginning of the year
What is CRISPR Therapeutics AG EV/EBITDA year-on-year change?
Over the past year, CRSP EV/EBITDA has changed by -1.28 (-19.08%)